Key result
Trans-septal endocardial LV lead implantation improves heart failure but is linked to a 9% stroke rate.
Why the study?
Trans-septal endocardial left ventricle lead placement is an alternative technique for endocardial LV capture, but its use has been limited by a lack of evidence, clinical trials, and practice uptake.
Does trans-septal endocardial left ventricle lead implant improve clinical and echocardiographic outcomes, and what is its safety profile in patients with challenging coronary sinus anatomy?
Observational
Does trans-septal endocardial left ventricle lead implant improve clinical and echocardiographic outcomes, and what is its safety profile in patients with challenging coronary sinus anatomy?
Answers are grounded in this paper and cite their sources.
Trans-septal endocardial LV lead implantation is a viable alternative for CRT in patients with failed coronary sinus anatomy, improving heart failure parameters but carrying a higher risk of stroke and procedural complications.
Background: Trans-septal endocardial left ventricle lead placement is an alternative technique used capture the left ventricular endocardially but it is use is limited due lack of evidence, practice uptake and clinical trials. we evaluated the efficiency of the procedure, post procedural complication rate, rate of thromboembolic events as well as changes in echocardiographic parameters, brain natriuretic peptide (BNP) level and the New York Heart Association (NYHA) class. Results: TSLV lead implant is safe, improves ejection fraction, LVEDV, LVESV, LVIDd. Significantly reduces NTproBNP levels and NYHA class. Stroke rate was reported only in one patient (9%), noticeably, this particular patient was on DOAC rather than anti-vitamin K antagonists. In this group, patients, who were on Warfarin , were not reported to have any thrombo-embolic events. Discussion: Trans-septal endocardial LV lead implant in patients with a failed CS approach remains a viable alternative however, there is a higher risk of stroke amongst these patients, as well as more procedure related risk of complications compared to conventional CRT. The data analysis demonstrates that patients undergoing a TSLV lead implant due to a failed trans-venous approach have more advanced heart failure, defined by their higher NYHA class compared to conventional trans-venous CRT implant groups. Their pre TSLV implant, echocardiographic parameters are also worse compared to trans-venous CRT implant group
No takes yet. Share an insight, caveat, or question.
Farhangee et al. (2023) conducted an observational in Heart failure with challenging coronary sinus anatomy requiring CRT. Trans-septal endocardial left ventricle (TSLV) lead implant vs. Conventional trans-venous CRT was evaluated on Stroke rate / thromboembolic events. Trans-septal endocardial left ventricle lead implantation improved heart failure parameters but was associated with a 9% stroke rate (1 patient), who was receiving a DOAC.
Synapse has enriched 10 related papers. Consider them for comparative context: